APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI-based Clinical Trial Solution

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global AI-based Clinical Trial Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

15 January 2026194 pages

Choose your research edition.

Industry ResearchAI-based Clinical Trial Solution Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal AI-based Clinical Trial Solution Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal AI-based Clinical Trial Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI-based Clinical Trial Solution Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal AI-based Clinical Trial Solution Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global AI-based Clinical Trial Solution market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for AI-based Clinical Trial Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI-based Clinical Trial Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI-based Clinical Trial Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for AI-based Clinical Trial Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of AI-based Clinical Trial Solution include AiCure, Antidote, Deep Lens, Saama Technologies, Trials.ai, Deep 6 AI, Innoplexus, Median Technologies and Mendel.ai, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global AI-based Clinical Trial Solution market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI-based Clinical Trial Solution and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI-based Clinical Trial Solution revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the AI-based Clinical Trial Solution market size, projected growth trends, production technologies, key applications, and end-use industries.

AI-based Clinical Trial Solution Segment by Company

AiCure

Antidote

Deep Lens

Saama Technologies

Trials.ai

Deep 6 AI

Innoplexus

Median Technologies

Mendel.ai

Phesi

Tempus

IBM

Digital Reasoning

Insilico Medicine

Insitro

Evotec

PathAI

Cancer Center.ai

AI-based Clinical Trial Solution Segment by Type

Artificial Narrow Intelligence

Artificial General Intelligence

Artificial Super Intelligence

AI-based Clinical Trial Solution Segment by Application

Drug Discovery

Drug Manufacturing

Drug Marketing

Diagnosis and Treatment

Clinical Trials

AI-based Clinical Trial Solution Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI-based Clinical Trial Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI-based Clinical Trial Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI-based Clinical Trial Solution.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of AI-based Clinical Trial Solution in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI-based Clinical Trial Solution industry.

Chapter 3: Detailed analysis of AI-based Clinical Trial Solution companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI-based Clinical Trial Solutionrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global AI-based Clinical Trial Solution Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Artificial Narrow Intelligence Table 3. Key Players of Artificial General Intelligence Table 4. Key Players of Artificial Super Intelligence Table 4. Global AI-based Clinical Trial Solution Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Drug Discovery Table 6. Key Players of Drug Manufacturing Table 7. Key Players of Drug Marketing Table 8. Key Players of Diagnosis and Treatment Table 9. Key Players of Clinical Trials Table 10. Global AI-based Clinical Trial Solution Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global AI-based Clinical Trial Solution Market Size by Region (2021-2026) & (US$ Million) Table 12. Global AI-based Clinical Trial Solution Market Share by Region (2021-2026) Table 13. Global AI-based Clinical Trial Solution Market Size by Region (2027-2032) & (US$ Million) Table 14. Global AI-based Clinical Trial Solution Market Share by Region (2027-2032) Table 15. AI-based Clinical Trial Solution Industry Trends Table 16. AI-based Clinical Trial Solution Industry Drivers Table 17. AI-based Clinical Trial Solution Industry Opportunities and Challenges Table 18. AI-based Clinical Trial Solution Industry Restraints Table 19. Global AI-based Clinical Trial Solution Revenue by Company (US$ Million) & (2021-2026) Table 20. Global AI-based Clinical Trial Solution Revenue Market Share by Company (2021-2026) Table 21. Global AI-based Clinical Trial Solution Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global AI-based Clinical Trial Solution Key Company Head Office and Area Served Table 23. Global AI-based Clinical Trial Solution Company, Product Type & Application Table 24. Global AI-based Clinical Trial Solution Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global AI-based Clinical Trial Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global AI-based Clinical Trial Solution Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global AI-based Clinical Trial Solution Market Size by Type (2021-2026) & (US$ Million) Table 29. Global AI-based Clinical Trial Solution Market Size by Type (2027-2032) & (US$ Million) Table 30. Global AI-based Clinical Trial Solution Revenue Market Share by Type (2021-2026) Table 31. Global AI-based Clinical Trial Solution Revenue Market Share by Type (2027-2032) Table 32. Global AI-based Clinical Trial Solution Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global AI-based Clinical Trial Solution Market Size by Application (2021-2026) & (US$ Million) Table 34. Global AI-based Clinical Trial Solution Market Size by Application (2027-2032) & (US$ Million) Table 35. Global AI-based Clinical Trial Solution Revenue Market Share by Application (2021-2026) Table 36. Global AI-based Clinical Trial Solution Revenue Market Share by Application (2027-2032) Table 37. AiCure Company Information Table 38. AiCure Business Overview Table 39. AiCure AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. AiCure AI-based Clinical Trial Solution Product Portfolio Table 41. AiCure Recent Development Table 42. Antidote Company Information Table 43. Antidote Business Overview Table 44. Antidote AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Antidote AI-based Clinical Trial Solution Product Portfolio Table 46. Antidote Recent Development Table 47. Deep Lens Company Information Table 48. Deep Lens Business Overview Table 49. Deep Lens AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Deep Lens AI-based Clinical Trial Solution Product Portfolio Table 51. Deep Lens Recent Development Table 52. Saama Technologies Company Information Table 53. Saama Technologies Business Overview Table 54. Saama Technologies AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Saama Technologies AI-based Clinical Trial Solution Product Portfolio Table 56. Saama Technologies Recent Development Table 57. Trials.ai Company Information Table 58. Trials.ai Business Overview Table 59. Trials.ai AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Trials.ai AI-based Clinical Trial Solution Product Portfolio Table 61. Trials.ai Recent Development Table 62. Deep 6 AI Company Information Table 63. Deep 6 AI Business Overview Table 64. Deep 6 AI AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Deep 6 AI AI-based Clinical Trial Solution Product Portfolio Table 66. Deep 6 AI Recent Development Table 67. Innoplexus Company Information Table 68. Innoplexus Business Overview Table 69. Innoplexus AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Innoplexus AI-based Clinical Trial Solution Product Portfolio Table 71. Innoplexus Recent Development Table 72. Median Technologies Company Information Table 73. Median Technologies Business Overview Table 74. Median Technologies AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Median Technologies AI-based Clinical Trial Solution Product Portfolio Table 76. Median Technologies Recent Development Table 77. Mendel.ai Company Information Table 78. Mendel.ai Business Overview Table 79. Mendel.ai AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Mendel.ai AI-based Clinical Trial Solution Product Portfolio Table 81. Mendel.ai Recent Development Table 82. Phesi Company Information Table 83. Phesi Business Overview Table 84. Phesi AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Phesi AI-based Clinical Trial Solution Product Portfolio Table 86. Phesi Recent Development Table 87. Tempus Company Information Table 88. Tempus Business Overview Table 89. Tempus AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. Tempus AI-based Clinical Trial Solution Product Portfolio Table 91. Tempus Recent Development Table 92. IBM Company Information Table 93. IBM Business Overview Table 94. IBM AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. IBM AI-based Clinical Trial Solution Product Portfolio Table 96. IBM Recent Development Table 97. Digital Reasoning Company Information Table 98. Digital Reasoning Business Overview Table 99. Digital Reasoning AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 100. Digital Reasoning AI-based Clinical Trial Solution Product Portfolio Table 101. Digital Reasoning Recent Development Table 102. Insilico Medicine Company Information Table 103. Insilico Medicine Business Overview Table 104. Insilico Medicine AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 105. Insilico Medicine AI-based Clinical Trial Solution Product Portfolio Table 106. Insilico Medicine Recent Development Table 107. Insitro Company Information Table 108. Insitro Business Overview Table 109. Insitro AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 110. Insitro AI-based Clinical Trial Solution Product Portfolio Table 111. Insitro Recent Development Table 112. Evotec Company Information Table 113. Evotec Business Overview Table 114. Evotec AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 115. Evotec AI-based Clinical Trial Solution Product Portfolio Table 116. Evotec Recent Development Table 117. PathAI Company Information Table 118. PathAI Business Overview Table 119. PathAI AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 120. PathAI AI-based Clinical Trial Solution Product Portfolio Table 121. PathAI Recent Development Table 122. Cancer Center.ai Company Information Table 123. Cancer Center.ai Business Overview Table 124. Cancer Center.ai AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 125. Cancer Center.ai AI-based Clinical Trial Solution Product Portfolio Table 126. Cancer Center.ai Recent Development Table 127. North America AI-based Clinical Trial Solution Market Size by Type (2021-2026) & (US$ Million) Table 128. North America AI-based Clinical Trial Solution Market Size by Type (2027-2032) & (US$ Million) Table 129. North America AI-based Clinical Trial Solution Market Size by Application (2021-2026) & (US$ Million) Table 130. North America AI-based Clinical Trial Solution Market Size by Application (2027-2032) & (US$ Million) Table 131. North America AI-based Clinical Trial Solution Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. North America AI-based Clinical Trial Solution Market Size by Country (2021-2026) Table 133. North America AI-based Clinical Trial Solution Market Size by Country (2027-2032) Table 134. Europe AI-based Clinical Trial Solution Market Size by Type (2021-2026) & (US$ Million) Table 135. Europe AI-based Clinical Trial Solution Market Size by Type (2027-2032) & (US$ Million) Table 136. Europe AI-based Clinical Trial Solution Market Size by Application (2021-2026) & (US$ Million) Table 137. Europe AI-based Clinical Trial Solution Market Size by Application (2027-2032) & (US$ Million) Table 138. Europe AI-based Clinical Trial Solution Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Europe AI-based Clinical Trial Solution Market Size by Country (2021-2026) Table 140. Europe AI-based Clinical Trial Solution Market Size by Country (2027-2032) Table 141. China AI-based Clinical Trial Solution Market Size by Type (2021-2026) & (US$ Million) Table 142. China AI-based Clinical Trial Solution Market Size by Type (2027-2032) & (US$ Million) Table 143. China AI-based Clinical Trial Solution Market Size by Application (2021-2026) & (US$ Million) Table 144. China AI-based Clinical Trial Solution Market Size by Application (2027-2032) & (US$ Million) Table 145. Asia AI-based Clinical Trial Solution Market Size by Type (2021-2026) & (US$ Million) Table 146. Asia AI-based Clinical Trial Solution Market Size by Type (2027-2032) & (US$ Million) Table 147. Asia AI-based Clinical Trial Solution Market Size by Application (2021-2026) & (US$ Million) Table 148. Asia AI-based Clinical Trial Solution Market Size by Application (2027-2032) & (US$ Million) Table 149. Asia AI-based Clinical Trial Solution Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. Asia AI-based Clinical Trial Solution Market Size by Country (2021-2026) Table 151. Asia AI-based Clinical Trial Solution Market Size by Country (2027-2032) Table 152. South America, Middle East & Africa AI-based Clinical Trial Solution Market Size by Type (2021-2026) & (US$ Million) Table 153. South America, Middle East & Africa AI-based Clinical Trial Solution Market Size by Type (2027-2032) & (US$ Million) Table 154. South America, Middle East & Africa AI-based Clinical Trial Solution Market Size by Application (2021-2026) & (US$ Million) Table 155. South America, Middle East & Africa AI-based Clinical Trial Solution Market Size by Application (2027-2032) & (US$ Million) Table 156. South America, Middle East & Africa AI-based Clinical Trial Solution Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. South America, Middle East & Africa AI-based Clinical Trial Solution Market Size by Country (2021-2026) Table 158. South America, Middle East & Africa AI-based Clinical Trial Solution Market Size by Country (2027-2032) Table 159. Research Programs/Design for This Report Table 160. Authors List of This Report Table 161. Secondary Sources Table 162. Primary Sources List of Figures Figure 1. AI-based Clinical Trial Solution Product Image Figure 2. Global AI-based Clinical Trial Solution Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global AI-based Clinical Trial Solution Market Share by Type: 2025 VS 2032 Figure 4. Artificial Narrow Intelligence Image Figure 5. Artificial General Intelligence Image Figure 6. Artificial Super Intelligence Image Figure 7. Global AI-based Clinical Trial Solution Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global AI-based Clinical Trial Solution Market Share by Application: 2025 VS 2032 Figure 9. Drug Discovery Image Figure 10. Drug Manufacturing Image Figure 11. Drug Marketing Image Figure 12. Diagnosis and Treatment Image Figure 13. Clinical Trials Image Figure 14. Global AI-based Clinical Trial Solution Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global AI-based Clinical Trial Solution Market Size (2021-2032) & (US$ Million) Figure 16. Global AI-based Clinical Trial Solution Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global AI-based Clinical Trial Solution Market Share by Players in 2025 Figure 19. Global Top 5 and 10 AI-based Clinical Trial Solution Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global AI-based Clinical Trial Solution Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global AI-based Clinical Trial Solution Revenue Market Share by Type (2021-2032) Figure 23. Global AI-based Clinical Trial Solution Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global AI-based Clinical Trial Solution Revenue Market Share by Application (2021-2032) Figure 25. North America AI-based Clinical Trial Solution Market Size (2021-2032) & (US$ Million) Figure 26. North America AI-based Clinical Trial Solution Market Share by Type (2021-2032) Figure 27. North America AI-based Clinical Trial Solution Market Share by Application (2021-2032) Figure 28. North America AI-based Clinical Trial Solution Market Share by Country (2021-2032) Figure 29. United States AI-based Clinical Trial Solution Market Size (2021-2032) & (US$ Million) Figure 30. Canada AI-based Clinical Trial Solution Market Size (2021-2032) & (US$ Million) Figure 31. Mexico AI-based Clinical Trial Solution Market Size (2021-2032) & (US$ Million) Figure 32. Europe AI-based Clinical Trial Solution Market Size (2021-2032) & (US$ Million) Figure 33. Europe AI-based Clinical Trial Solution Market Share by Type (2021-2032) Figure 34. Europe AI-based Clinical Trial Solution Market Share by Application (2021-2032) Figure 35. Europe AI-based Clinical Trial Solution Market Share by Country (2021-2032) Figure 36. Germany AI-based Clinical Trial Solution Market Size (2021-2032) & (US$ Million) Figure 37. France AI-based Clinical Trial Solution Market Size (2021-2032) & (US$ Million) Figure 38. U.K. AI-based Clinical Trial Solution Market Size (2021-2032) & (US$ Million) Figure 39. Italy AI-based Clinical Trial Solution Market Size (2021-2032) & (US$ Million) Figure 40. Russia AI-based Clinical Trial Solution Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries AI-based Clinical Trial Solution Market Size (2021-2032) & (US$ Million) Figure 42. China AI-based Clinical Trial Solution Market Size (2021-2032) & (US$ Million) Figure 43. China AI-based Clinical Trial Solution Market Share by Type (2021-2032) Figure 44. China AI-based Clinical Trial Solution Market Share by Application (2021-2032) Figure 45. Asia AI-based Clinical Trial Solution Market Size (2021-2032) & (US$ Million) Figure 46. Asia AI-based Clinical Trial Solution Market Share by Type (2021-2032) Figure 47. Asia AI-based Clinical Trial Solution Market Share by Application (2021-2032) Figure 48. Asia AI-based Clinical Trial Solution Market Share by Country (2021-2032) Figure 49. Japan AI-based Clinical Trial Solution Market Size (2021-2032) & (US$ Million) Figure 50. South Korea AI-based Clinical Trial Solution Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan AI-based Clinical Trial Solution Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia AI-based Clinical Trial Solution Market Size (2021-2032) & (US$ Million) Figure 53. India AI-based Clinical Trial Solution Market Size (2021-2032) & (US$ Million) Figure 54. Australia AI-based Clinical Trial Solution Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa AI-based Clinical Trial Solution Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa AI-based Clinical Trial Solution Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa AI-based Clinical Trial Solution Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa AI-based Clinical Trial Solution Market Share by Country (2021-2032) Figure 59. Brazil AI-based Clinical Trial Solution Market Size (2021-2032) & (US$ Million) Figure 60. South Africa AI-based Clinical Trial Solution Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia AI-based Clinical Trial Solution Market Size (2021-2032) & (US$ Million) Figure 62. Turkey AI-based Clinical Trial Solution Market Size (2021-2032) & (US$ Million) Figure 63. Argentina AI-based Clinical Trial Solution Market Size (2021-2032) & (US$ Million) Figure 64. UAE AI-based Clinical Trial Solution Market Size (2021-2032) & (US$ Million) Figure 65. Egypt AI-based Clinical Trial Solution Market Size (2021-2032) & (US$ Million) Figure 66. Chile AI-based Clinical Trial Solution Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Artificial Narrow Intelligence
  • Artificial General Intelligence
  • Artificial Super Intelligence
Applications
  • Drug Discovery
  • Drug Manufacturing
  • Drug Marketing
  • Diagnosis and Treatment
  • Clinical Trials
Companies covered
  • AiCure
  • Antidote
  • Deep Lens
  • Saama Technologies
  • Trials.ai
  • Deep 6 AI
  • Innoplexus
  • Median Technologies
  • Mendel.ai
  • Phesi
  • Tempus
  • IBM
  • Digital Reasoning
  • Insilico Medicine
  • Insitro
  • Evotec
  • PathAI
  • Cancer Center.ai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global AI-based Clinical Trial Solution Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Artificial Narrow Intelligence
  5. 1.2.3 Artificial General Intelligence
  6. 1.2.4 Artificial Super Intelligence
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global AI-based Clinical Trial Solution Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Drug Discovery
  10. 1.3.3 Drug Manufacturing
  11. 1.3.4 Drug Marketing
  12. 1.3.5 Diagnosis and Treatment
  13. 1.3.6 Clinical Trials
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global AI-based Clinical Trial Solution Growth Trends by Region
  16. 1.5.1 Global AI-based Clinical Trial Solution Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 AI-based Clinical Trial Solution Market Size by Region (2021-2026)
  18. 1.5.3 AI-based Clinical Trial Solution Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global AI-based Clinical Trial Solution Market Dynamics
  1. 2.1 AI-based Clinical Trial Solution Industry Trends
  2. 2.2 AI-based Clinical Trial Solution Industry Drivers
  3. 2.3 AI-based Clinical Trial Solution Industry Opportunities and Challenges
  4. 2.4 AI-based Clinical Trial Solution Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global AI-based Clinical Trial Solution Revenue by Company (2021-2026)
  2. 3.2 Global AI-based Clinical Trial Solution Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global AI-based Clinical Trial Solution Key Company Head office and Area Served
  4. 3.4 Global AI-based Clinical Trial Solution Company, Product Type & Application
  5. 3.5 Global AI-based Clinical Trial Solution Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global AI-based Clinical Trial Solution Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 AI-based Clinical Trial Solution Players Market Share by Revenue in 2025
  9. 3.6.3 2025 AI-based Clinical Trial Solution Tier 1, Tier 2, and Tier 3
4 AI-based Clinical Trial Solution Market by Type
  1. 4.1 Global AI-based Clinical Trial Solution Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global AI-based Clinical Trial Solution Market Size by Type (2021-2032)
  3. 4.3 Global AI-based Clinical Trial Solution Market Size Share by Type (2021-2032)
5 AI-based Clinical Trial Solution Market by Application
  1. 5.1 Global AI-based Clinical Trial Solution Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global AI-based Clinical Trial Solution Market Size by Application (2021-2032)
  3. 5.3 Global AI-based Clinical Trial Solution Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 AiCure
  2. 6.1.1 AiCure Company Information
  3. 6.1.2 AiCure Business Overview
  4. 6.1.3 AiCure AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 AiCure AI-based Clinical Trial Solution Product Portfolio
  6. 6.1.5 AiCure Recent Developments
  7. 6.2 Antidote
  8. 6.2.1 Antidote Company Information
  9. 6.2.2 Antidote Business Overview
  10. 6.2.3 Antidote AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Antidote AI-based Clinical Trial Solution Product Portfolio
  12. 6.2.5 Antidote Recent Developments
  13. 6.3 Deep Lens
  14. 6.3.1 Deep Lens Company Information
  15. 6.3.2 Deep Lens Business Overview
  16. 6.3.3 Deep Lens AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Deep Lens AI-based Clinical Trial Solution Product Portfolio
  18. 6.3.5 Deep Lens Recent Developments
  19. 6.4 Saama Technologies
  20. 6.4.1 Saama Technologies Company Information
  21. 6.4.2 Saama Technologies Business Overview
  22. 6.4.3 Saama Technologies AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Saama Technologies AI-based Clinical Trial Solution Product Portfolio
  24. 6.4.5 Saama Technologies Recent Developments
  25. 6.5 Trials.ai
  26. 6.5.1 Trials.ai Company Information
  27. 6.5.2 Trials.ai Business Overview
  28. 6.5.3 Trials.ai AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Trials.ai AI-based Clinical Trial Solution Product Portfolio
  30. 6.5.5 Trials.ai Recent Developments
  31. 6.6 Deep 6 AI
  32. 6.6.1 Deep 6 AI Company Information
  33. 6.6.2 Deep 6 AI Business Overview
  34. 6.6.3 Deep 6 AI AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Deep 6 AI AI-based Clinical Trial Solution Product Portfolio
  36. 6.6.5 Deep 6 AI Recent Developments
  37. 6.7 Innoplexus
  38. 6.7.1 Innoplexus Company Information
  39. 6.7.2 Innoplexus Business Overview
  40. 6.7.3 Innoplexus AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Innoplexus AI-based Clinical Trial Solution Product Portfolio
  42. 6.7.5 Innoplexus Recent Developments
  43. 6.8 Median Technologies
  44. 6.8.1 Median Technologies Company Information
  45. 6.8.2 Median Technologies Business Overview
  46. 6.8.3 Median Technologies AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Median Technologies AI-based Clinical Trial Solution Product Portfolio
  48. 6.8.5 Median Technologies Recent Developments
  49. 6.9 Mendel.ai
  50. 6.9.1 Mendel.ai Company Information
  51. 6.9.2 Mendel.ai Business Overview
  52. 6.9.3 Mendel.ai AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Mendel.ai AI-based Clinical Trial Solution Product Portfolio
  54. 6.9.5 Mendel.ai Recent Developments
  55. 6.10 Phesi
  56. 6.10.1 Phesi Company Information
  57. 6.10.2 Phesi Business Overview
  58. 6.10.3 Phesi AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Phesi AI-based Clinical Trial Solution Product Portfolio
  60. 6.10.5 Phesi Recent Developments
  61. 6.11 Tempus
  62. 6.11.1 Tempus Company Information
  63. 6.11.2 Tempus Business Overview
  64. 6.11.3 Tempus AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Tempus AI-based Clinical Trial Solution Product Portfolio
  66. 6.11.5 Tempus Recent Developments
  67. 6.12 IBM
  68. 6.12.1 IBM Company Information
  69. 6.12.2 IBM Business Overview
  70. 6.12.3 IBM AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 IBM AI-based Clinical Trial Solution Product Portfolio
  72. 6.12.5 IBM Recent Developments
  73. 6.13 Digital Reasoning
  74. 6.13.1 Digital Reasoning Company Information
  75. 6.13.2 Digital Reasoning Business Overview
  76. 6.13.3 Digital Reasoning AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Digital Reasoning AI-based Clinical Trial Solution Product Portfolio
  78. 6.13.5 Digital Reasoning Recent Developments
  79. 6.14 Insilico Medicine
  80. 6.14.1 Insilico Medicine Company Information
  81. 6.14.2 Insilico Medicine Business Overview
  82. 6.14.3 Insilico Medicine AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Insilico Medicine AI-based Clinical Trial Solution Product Portfolio
  84. 6.14.5 Insilico Medicine Recent Developments
  85. 6.15 Insitro
  86. 6.15.1 Insitro Company Information
  87. 6.15.2 Insitro Business Overview
  88. 6.15.3 Insitro AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Insitro AI-based Clinical Trial Solution Product Portfolio
  90. 6.15.5 Insitro Recent Developments
  91. 6.16 Evotec
  92. 6.16.1 Evotec Company Information
  93. 6.16.2 Evotec Business Overview
  94. 6.16.3 Evotec AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Evotec AI-based Clinical Trial Solution Product Portfolio
  96. 6.16.5 Evotec Recent Developments
  97. 6.17 PathAI
  98. 6.17.1 PathAI Company Information
  99. 6.17.2 PathAI Business Overview
  100. 6.17.3 PathAI AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 PathAI AI-based Clinical Trial Solution Product Portfolio
  102. 6.17.5 PathAI Recent Developments
  103. 6.18 Cancer Center.ai
  104. 6.18.1 Cancer Center.ai Company Information
  105. 6.18.2 Cancer Center.ai Business Overview
  106. 6.18.3 Cancer Center.ai AI-based Clinical Trial Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Cancer Center.ai AI-based Clinical Trial Solution Product Portfolio
  108. 6.18.5 Cancer Center.ai Recent Developments
7 North America
  1. 7.1 North America AI-based Clinical Trial Solution Market Size (2021-2032)
  2. 7.2 North America AI-based Clinical Trial Solution Market Size by Type
  3. 7.2.1 North America AI-based Clinical Trial Solution Market Size by Type (2021-2026)
  4. 7.2.2 North America AI-based Clinical Trial Solution Market Size by Type (2027-2032)
  5. 7.2.3 North America AI-based Clinical Trial Solution Market Share by Type (2021-2032)
  6. 7.3 North America AI-based Clinical Trial Solution Market Size by Application
  7. 7.3.1 North America AI-based Clinical Trial Solution Market Size by Application (2021-2026)
  8. 7.3.2 North America AI-based Clinical Trial Solution Market Size by Application (2027-2032)
  9. 7.3.3 North America AI-based Clinical Trial Solution Market Share by Application (2021-2032)
  10. 7.4 North America AI-based Clinical Trial Solution Market Size by Country
  11. 7.4.1 North America AI-based Clinical Trial Solution Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America AI-based Clinical Trial Solution Market Size by Country (2021-2026)
  13. 7.4.3 North America AI-based Clinical Trial Solution Market Size by Country (2027-2032)
  14. 7.4.4 North America AI-based Clinical Trial Solution Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe AI-based Clinical Trial Solution Market Size (2021-2032)
  2. 8.2 Europe AI-based Clinical Trial Solution Market Size by Type
  3. 8.2.1 Europe AI-based Clinical Trial Solution Market Size by Type (2021-2026)
  4. 8.2.2 Europe AI-based Clinical Trial Solution Market Size by Type (2027-2032)
  5. 8.2.3 Europe AI-based Clinical Trial Solution Market Share by Type (2021-2032)
  6. 8.3 Europe AI-based Clinical Trial Solution Market Size by Application
  7. 8.3.1 Europe AI-based Clinical Trial Solution Market Size by Application (2021-2026)
  8. 8.3.2 Europe AI-based Clinical Trial Solution Market Size by Application (2027-2032)
  9. 8.3.3 Europe AI-based Clinical Trial Solution Market Share by Application (2021-2032)
  10. 8.4 Europe AI-based Clinical Trial Solution Market Size by Country
  11. 8.4.1 Europe AI-based Clinical Trial Solution Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe AI-based Clinical Trial Solution Market Size by Country (2021-2026)
  13. 8.4.3 Europe AI-based Clinical Trial Solution Market Size by Country (2027-2032)
  14. 8.4.4 Europe AI-based Clinical Trial Solution Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China AI-based Clinical Trial Solution Market Size (2021-2032)
  2. 9.2 China AI-based Clinical Trial Solution Market Size by Type
  3. 9.2.1 China AI-based Clinical Trial Solution Market Size by Type (2021-2026)
  4. 9.2.2 China AI-based Clinical Trial Solution Market Size by Type (2027-2032)
  5. 9.2.3 China AI-based Clinical Trial Solution Market Share by Type (2021-2032)
  6. 9.3 China AI-based Clinical Trial Solution Market Size by Application
  7. 9.3.1 China AI-based Clinical Trial Solution Market Size by Application (2021-2026)
  8. 9.3.2 China AI-based Clinical Trial Solution Market Size by Application (2027-2032)
  9. 9.3.3 China AI-based Clinical Trial Solution Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia AI-based Clinical Trial Solution Market Size (2021-2032)
  2. 10.2 Asia AI-based Clinical Trial Solution Market Size by Type
  3. 10.2.1 Asia AI-based Clinical Trial Solution Market Size by Type (2021-2026)
  4. 10.2.2 Asia AI-based Clinical Trial Solution Market Size by Type (2027-2032)
  5. 10.2.3 Asia AI-based Clinical Trial Solution Market Share by Type (2021-2032)
  6. 10.3 Asia AI-based Clinical Trial Solution Market Size by Application
  7. 10.3.1 Asia AI-based Clinical Trial Solution Market Size by Application (2021-2026)
  8. 10.3.2 Asia AI-based Clinical Trial Solution Market Size by Application (2027-2032)
  9. 10.3.3 Asia AI-based Clinical Trial Solution Market Share by Application (2021-2032)
  10. 10.4 Asia AI-based Clinical Trial Solution Market Size by Country
  11. 10.4.1 Asia AI-based Clinical Trial Solution Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia AI-based Clinical Trial Solution Market Size by Country (2021-2026)
  13. 10.4.3 Asia AI-based Clinical Trial Solution Market Size by Country (2027-2032)
  14. 10.4.4 Asia AI-based Clinical Trial Solution Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa AI-based Clinical Trial Solution Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa AI-based Clinical Trial Solution Market Size by Type
  3. 11.2.1 South America, Middle East & Africa AI-based Clinical Trial Solution Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa AI-based Clinical Trial Solution Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa AI-based Clinical Trial Solution Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa AI-based Clinical Trial Solution Market Size by Application
  7. 11.3.1 South America, Middle East & Africa AI-based Clinical Trial Solution Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa AI-based Clinical Trial Solution Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa AI-based Clinical Trial Solution Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa AI-based Clinical Trial Solution Market Size by Country
  11. 11.4.1 South America, Middle East & Africa AI-based Clinical Trial Solution Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa AI-based Clinical Trial Solution Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa AI-based Clinical Trial Solution Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa AI-based Clinical Trial Solution Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst